Untitled Document
Hathaway Corporation - Your next step

Call Us: 817-812-2104
"The future is now"
Building tomorrow's technology through today's innovations.
 
 


 Home:  
 
About Hathaway Companies Investors Contact Us

Company news:

Corporate Home:


Stock quote
: HWYI

Opticon Systems Home:
Diabetic Detection Inc:

Hathaway (HWYI) Enters into LOI with Korean
Medical device Manufacturer, U & I Bio-Tech, Inc.
More >>

Hathaway (HWYI) Subsidiary OptiCon Systems, Inc. Receives Trading
Symbol from FINRA
More >>

Hathaway (HWYI) to Begin Spin-Off of Subsidiary Diabetes Detection Inc.
More >>

Hathaway Corporation Responds to Investors Concerns Regarding Stock Price

Monday March 20, 2006

Hathaway Corporation has received many shareholder concerns regarding the falling share price over the past few weeks.

"As with most public companies, Hathaway has no control in how trades ensue or how markets are made for the company's securities. We have uncovered facts there may be certain unscrupulous individuals and/or companies that might be behind a manipulation of our stock prices. We will thoroughly investigate and if we find these facts to be true, the company will use all legal means to prosecute any individuals or companies found to be responsible for any manipulation of our share price and/or trading improprieties," stated Mr. Paul D. Lisenby, acting CEO of Hathaway. Mr. Lisenby goes on to say, "As for our operations at Hathaway Corporation, we are executing our business plans to its fullest. Mr. Larry Oakley of wallstreetcorner.com stated that 'Hathaway Corporation Business Model Seen as Extraordinarily Attractive.' We have accomplished this through the acquisition of two communications companies that bring a major transformation to their respective industries: OptiCon Systems and Diabetes Detection, Inc. Both acquisitions were done based on $1.00 per share of Hathaway stock."

In addition, the company also stated the following:

OptiCon Systems is in the process of securing funding by major investment bankers for $30M. Their projected financials call for the annualized revenue of $3 million, $50 million, and $125 million over the next three years.

Diabetes Detection has the world's only patent-pending technology that utilizes current communication devices for early detection of diabetes. The device will allow every person to use common devices such as cell phones or a BlackBerry® for early detection of diabetes.

About Hathaway Corporation

Hathaway Corporation develops and acquires undervalued companies that bring a shift in how communications is delivered and serviced globally. Starting with OptiCon Systems, which is used by Global 500 companies, Hathaway will continue to seek out and capitalize on emerging technologies that will change the way the world communicates. Hathaway brings the communications solutions of the future to today's business marketplace.

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

Back >>

Untitled Document
Home | About |Companies |Investors | Contact Us
© 2008 - Hathaway Global, inc. , all rights reserved